These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1613568)

  • 21. Departures from manufacturer's instructions; elimination of recordkeeping requirements--NRC. Final rule.
    Fed Regist; 1992 Oct; 57(192):45566-8. PubMed ID: 10121203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New NRC rule spurred by radiation incidents. Motivated by two recent acts of suspected radiation sabotage, the Nuclear Regulatory Commission wants any future events to be reported within 24 hours. Will the new rule prevent international misadministrations or just cause unnecessary paperwork?
    Kotz D
    J Nucl Med; 1996 Jun; 37(6):15N-9N. PubMed ID: 8683302
    [No Abstract]   [Full Text] [Related]  

  • 23. Medical use of byproduct material; policy statement, revision. Nuclear Regulatory Commission. Final policy statement; revision.
    Fed Regist; 2000 Aug; 65(150):47654-60. PubMed ID: 11067710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medical administration of radiation and radioactive materials--NRC. Final rule.
    Fed Regist; 1995 Sep; 60(182):48623-6. PubMed ID: 10151185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nuclear medicine.
    Davis S
    NCSL Legisbrief; 2000 Oct; 8(41):1-2. PubMed ID: 11850887
    [No Abstract]   [Full Text] [Related]  

  • 26. The AAPM should develop protocols generically, and avoid documents that are too strict and prescriptive, to facilitate their adoption by regulatory agencies like the Nuclear Regulatory Commission and States.
    Jones CG; Thomadsen B
    Med Phys; 2000 Mar; 27(3):431-3. PubMed ID: 10757592
    [No Abstract]   [Full Text] [Related]  

  • 27. Medical use of byproduct material; draft policy statement--NRC. draft policy statement.
    Fed Regist; 1998 Aug; 63(156):43580-6. PubMed ID: 10182574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Government relations update.
    Sullivan A
    J Nucl Med Technol; 1999 Sep; 27(3):259-60. PubMed ID: 10512486
    [No Abstract]   [Full Text] [Related]  

  • 29. Early closing of accelerator could impede nuclear medicine research.
    Rojas-Burke J
    J Nucl Med; 1993 Jun; 34(6):51N, 54N-55N. PubMed ID: 8509851
    [No Abstract]   [Full Text] [Related]  

  • 30. The Department of Energy's role in isotope availability for nuclear medicine research.
    Lash TR
    J Nucl Med; 1998 May; 39(5):22N, 25N. PubMed ID: 9591567
    [No Abstract]   [Full Text] [Related]  

  • 31. Quality management program and misadministrations; NRC override of OMB disapproval of NRC information collection request--Nuclear Regulatory Commission. Final rule.
    Fed Regist; 1992 Sep; 57(176):41376-8. PubMed ID: 10121196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Not nuclear medicine: the government's radiobiological and other experiments.
    Miller L
    J Nucl Med; 1994 Mar; 35(3):9N-12N, 16N, 22N. PubMed ID: 8113911
    [No Abstract]   [Full Text] [Related]  

  • 33. Medical use of byproduct material; proposed revision--NRC. Proposal rule.
    Fed Regist; 1998 Aug; 63(156):43516-80. PubMed ID: 10182573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lines from the president: dispelling the confusion about radiation safety in medicine.
    Murphy PH
    J Nucl Med; 1993 Mar; 34(3):34N, 40N. PubMed ID: 8441022
    [No Abstract]   [Full Text] [Related]  

  • 35. Government officials urge nuclear physicians to be more active in political process.
    Kotz D
    J Nucl Med; 1999 May; 40(5):13N, 15N, 31N. PubMed ID: 10319737
    [No Abstract]   [Full Text] [Related]  

  • 36. Public affairs update.
    Uffelman W
    J Nucl Med; 2004 Mar; 45(3):33N. PubMed ID: 15001672
    [No Abstract]   [Full Text] [Related]  

  • 37. Medical use of byproduct material: issues and request for public input--NRC. Request for public input on rule development.
    Fed Regist; 1997 Aug; 62(151):42219-20. PubMed ID: 10169835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Launching "molecular nuclear medicine" grants, DOE scales back funding for medical applications programs.
    J Nucl Med; 1993 Feb; 34(2):15N-16N. PubMed ID: 8429331
    [No Abstract]   [Full Text] [Related]  

  • 39. Limited revision of fee schedules--NRC. Final rule.
    Fed Regist; 1992 Apr; 57(75):13625-34. PubMed ID: 10118460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NRC regulations on departures from manufacturer's instructions.
    Hung JC
    J Nucl Med; 1993 Mar; 34(3):523-4. PubMed ID: 8441050
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.